Sector consensus BioRestorative Therapies, Inc.
Stocks
BRTX
US0906557055
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:30:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 2.550 USD | +1.59% |
|
-5.20% | -89.15% |
| 09-02 | BioRestorative Therapies, Inc. Announces CEO Changes, Effective August 26, 2026 | CI |
| 09-02 | BioRestorative Therapies, Inc. Announces CFO Changes, Effective August 27, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 160 | +6,274.5% | 2 | |||||
| 187.07 | +15.19% | 18 | ||||||
| 1,176.01 | +23.91% | 15 | ||||||
| 49.73 | +12.16% | 24 | ||||||
| 199.04 | +63.75% | 23 | ||||||
| 103.07 | +18.06% | 20 | ||||||
| 2,303.24 | +1.55% | 16 | ||||||
| 1,397.26 | +20.98% | 8 | ||||||
| 53.69 | -7.36% | 16 | ||||||
| 619.67 | +32.98% | 19 | ||||||
| 21.6 | +74.27% | 13 | ||||||
| 682.11 | +32.91% | 18 | ||||||
| 133.11 | +65.66% | 21 | ||||||
| 107.23 | +62.3% | 13 | ||||||
| 12.75 | +47.57% | 4 | ||||||
| 109.9 | +67.38% | 20 | ||||||
| 109 | +91.56% | 9 | ||||||
| 100.16 | +60.47% | 16 | ||||||
| 120.08 | +37.88% | 13 | ||||||
| - | - | - | - | - | ||||
| Average | 402.35 | +368.20% | 15 | ||||||
| Weighted average by Cap. | 511.49 | +30.35% | 17 |
- Stock Market
- Stocks
- BRTX Stock
- Sector BioRestorative Therapies, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
